Medical Experts Call for Urgent Action as Heavy Menstrual Bleeding Impacts Half of Reproductive-Aged Women

Heavy Menstrual Bleeding (HMB) is increasingly being recognized by medical professionals as a significant health crisis rather than a mere lifestyle inconvenience. Affecting a substantial portion of reproductive-aged women, HMB is frequently a primary symptom of underlying and often painful conditions such as uterine fibroids and endometriosis. Despite its prevalence, health experts warn that the condition remains chronically underestimated, leading to severe impacts on the physical and psychological well-being of women worldwide and within the Ghanaian context. Current clinical studies suggest that between 10% and 30% of women experience HMB, yet many researchers believe these figures represent only a fraction of the actual burden. Due to societal stigmas and the normalization of menstrual pain, underreporting is rampant, with some estimates suggesting that up to 50% of women may actually suffer from the condition. This discrepancy highlights a critical gap in public health awareness and the medical community’s historical tendency to overlook menstrual health as a priority area for intensive study. The medical response to HMB has been characterized by a slow evolution in treatment options. While doctors are beginning to acknowledge the severity of the issue, existing therapies are often described as insufficient or come with significant side effects. The lack of robust research funding has hindered the development of innovative, non-invasive treatments, leaving many women to manage personal and societal consequences—ranging from workplace productivity loss to severe iron-deficiency anemia—on their own. Moving forward, advocates and health professionals are calling for a fundamental shift in how menstrual health is researched and managed. Addressing the silent epidemic of heavy periods requires a multi-pronged approach: improving diagnostic tools, fostering open societal dialogue to encourage reporting, and prioritizing funding for specialized research into fibroids and endometriosis. As awareness grows, the goal remains to transform the medical narrative from one of passive tolerance to proactive, effective intervention.